Pharma scale-up to market: operating model design and investor-readiness
European Customer Consultancy (ECC)
Service ID:
EP386S1Intensive programme for pharma/biotech scale-ups (TRL 5–9) combining executive guidance on operating model design with structured mentoring for corporate partnerships success. We help you de-risk your scale-up trajectory and build strong relationships with corporates who need what you've built.
Our approach is shaped by senior pharma executives—people who've scaled divisions, managed corporate partnerships, and understand what investors and corporates actually look for in an innovation partner. They advise on readiness and support the execution.
Step 1 – Operational Readiness Diagnostic (SORS™)
The programme begins with SORS™ (Startup Operational Readiness Scorecard), a structured assessment of your growth foundations. The output diagnoses your scaling-up risks across all critical dimensions: team & HR, customer management, product development, process scalability, technology infrastructure including AI, financial operations, and legal & compliance. Outcome: Participants receive a roadmap to a successful corporate integration and partnership strategy.
Step 2 – Business Planning
Co-design the organizational and process infrastructure your pharma scale-up needs to grow from validated innovation to market-ready execution. We will pair you up with an executive specialized in pharma, including rare disease and orphan drugs, or biotech. Outcome: Investor-ready operating roadmap.
Step 3 – Mentoring and Execution
Ongoing 1-on-1 mentoring with senior pharma executives. We embed alongside your team to ensure the roadmap lands with your people and builds the credibility you'll need with corporate partners, investors, and regulators. Focus: governance, team scaling, customer value growth, fundraising readiness, corporate partnership navigation. Outcome: Executable operating model, corporate partnership readiness, closing the execution gap.
The programme is offered on a paid basis. It includes SORS™ operational readiness assessment, operating model co-design expert workshop, up to 4 half-day workshops and up to 12 mentoring sessions with senior pharma leaders. Face-to-face delivery is possible, with travel and venue costs agreed separately. No equity is requested. EIC beneficiaries may benefit from preferential conditions, including discounts of up to 20% depending on scope and delivery format. Programme cost: €18,500.
Service delivery is subject to intake assessment. Start dates are agreed individually. Delivery may be online, hybrid or f2f depending on participant needs and mentor availability. ECC reserves the right to adapt programme scope to ensure alignment with innovation maturity, operational readiness and expected outcomes.
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project website.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.